Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N 6 -methyladenosine (m 6 A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules

1 Sept 2020

Abstract excerpt

Objective Although N 6 -methyladenosine (m 6 A) RNA methylation is the most common mRNA modification process, few studies have examined the role of m 6 A in stomach adenocarcinomas (STADs). Methods In this retrospective study, we analyzed 293 STAD samples from The Cancer Genome Atlas with complete clinicopathological feature profiles. The m 6 A methylation risk signature was derived from LASSO–Cox regression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32972288
DOI: 10.1177/0300060520951405

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N 6 -methyladenosine (m 6 A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint moleculesPMID 32972288Read ↗

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survivalSemantic proximity Read ↗

N6-methyladenosine demethylase FTO serves as an indicator for predicting prognosis and immunotherapy response in individuals with gastric cancerSemantic proximity Read ↗

m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancerSemantic proximity Read ↗

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAsSemantic proximity Read ↗

Disulfidptosis-related lncRNA signature reveals immune microenvironment and novel molecular subtyping of stomach adenocarcinomaSemantic proximity Read ↗

Deciphering N6‐Methyladenosine‐Related Genes Signature to Predict Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Landscape Of M6a RNA Methylation Regulators and Tumor Microenvironment Cell-Infiltration Characterization In Gastroesophageal AdenocarcinomasSemantic proximity Read ↗

A m6A-related lncRNA Signature as a Novel Prognostic Factor for Gastric CancerSemantic proximity Read ↗

Identification of Prognosis Signature and Analysis of the Immune Microenvironment in Gastric Cancer Based on ALKBH5Semantic proximity Read ↗

Establishment of a 5 DNA Methylation Site Prognostic Signature Associated with N6-Methyladenosine in Lung AdenocarcinomaSemantic proximity Read ↗

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerSemantic proximity Read ↗

A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.